Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GW Pharmaceuticals Plc GWPHV



NDAQ:GWPHV - Post by User

GW Pharmaceuticals Plc > GWPH is just getting started in Europe
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(76)
•••
Comment by Isodog2018on Dec 09, 2019 12:06pm
143 Views
Post# 30436080

RE:GWPH is just getting started in Europe

RE:GWPH is just getting started in Europe
Isodog2018 wrote:

Study results showed EPIDIOLEX significantly reduced difficult-to-treat seizures associated with TSC and improved overall patient condition as reported by caregivers 
 

https://ir.gwpharm.com/node/11091/pdf


 

I'm selling,.....lol,.....f*ucking shorts,.......Sell order is at $180 USD.

Shhh, I'm buying up to $110 as well,.....

These shorts are doing us a favour,......buy,.......strong buy!

Cheers

 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities